Shandong Pharmaceutical Glass Co Ltd (600529) — Financial Flexibility Index
Shandong Pharmaceutical Glass Co Ltd (600529) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥194.64 Million (operating CF CN¥41.46 Million minus capex CN¥153.18 Million) represents 0% of total liabilities (CN¥1.75 Billion). Check strategic asset allocation of Shandong Pharmaceutical Glass Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Pharmaceutical Glass Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. See working capital to net assets of Shandong Pharmaceutical Glass Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Shandong Pharmaceutical Glass Co Ltd. For the full company profile including market capitalisation, see Shandong Pharmaceutical Glass Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥808.79 Million | CN¥576.92 Million | CN¥1.75 Billion | ▼ -45.6% |
| 2024 | 0.85x | CN¥1.81 Billion | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -11.8% |
| 2023 | 0.96x | CN¥1.72 Billion | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +82.4% |
| 2022 | 0.53x | CN¥963.16 Million | CN¥252.44 Million | CN¥1.82 Billion | ▼ -41.1% |
| 2021 | 0.90x | CN¥1.56 Billion | CN¥750.44 Million | CN¥1.74 Billion | ▲ +11.2% |
| 2020 | 0.81x | CN¥1.10 Billion | CN¥566.01 Million | CN¥1.37 Billion | ▼ -11.8% |
| 2019 | 0.91x | CN¥1.19 Billion | CN¥599.05 Million | CN¥1.30 Billion | ▲ +23.4% |
| 2018 | 0.74x | CN¥813.16 Million | CN¥465.77 Million | CN¥1.10 Billion | ▲ +18.9% |
| 2017 | 0.62x | CN¥579.03 Million | CN¥411.96 Million | CN¥929.84 Million | ▼ -23.8% |
| 2016 | 0.82x | CN¥703.11 Million | CN¥506.53 Million | CN¥860.62 Million | ▲ +10.3% |
| 2015 | 0.74x | CN¥544.75 Million | CN¥389.63 Million | CN¥735.61 Million | ▲ +28.2% |
| 2014 | 0.58x | CN¥400.16 Million | CN¥266.63 Million | CN¥692.56 Million | ▼ -6.9% |
| 2013 | 0.62x | CN¥419.09 Million | CN¥268.60 Million | CN¥675.48 Million | ▲ +176.7% |
| 2012 | 0.22x | CN¥150.62 Million | CN¥28.52 Million | CN¥671.80 Million | ▼ -70.6% |
| 2011 | 0.76x | CN¥492.15 Million | CN¥274.63 Million | CN¥644.80 Million | ▲ +42.3% |
| 2010 | 0.54x | CN¥417.38 Million | CN¥217.01 Million | CN¥778.34 Million | ▼ -9.1% |
| 2009 | 0.59x | CN¥367.71 Million | CN¥249.27 Million | CN¥623.51 Million | ▲ +26.0% |
| 2008 | 0.47x | CN¥250.15 Million | CN¥91.76 Million | CN¥534.52 Million | ▼ -6.8% |
| 2007 | 0.50x | CN¥283.46 Million | CN¥122.63 Million | CN¥564.66 Million | ▲ +137.7% |
| 2006 | 0.21x | CN¥149.06 Million | CN¥78.47 Million | CN¥705.86 Million | ▼ -7.8% |
| 2005 | 0.23x | CN¥129.18 Million | CN¥44.09 Million | CN¥564.27 Million | ▼ -30.1% |
| 2004 | 0.33x | CN¥142.42 Million | CN¥-3.70 Million | CN¥434.85 Million | ▼ -69.3% |
| 2003 | 1.07x | CN¥331.09 Million | CN¥59.35 Million | CN¥310.80 Million | ▲ +40.9% |
| 2002 | 0.76x | CN¥221.75 Million | CN¥109.26 Million | CN¥293.28 Million | ▲ +240.6% |
| 2001 | 0.22x | CN¥53.92 Million | CN¥28.60 Million | CN¥242.90 Million | — |